Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
Envelope proteins of human T-cell leukemia virus: expression in Escherichia coli and its application to studies of env gene functions.
Proc Natl Acad Sci U S A. 1984 Oct;81(19):6202-6. Unique Identifier : AIDSLINE MED/85014934 Kiyokawa T; Yoshikura H; Hattori S; Seiki M; Yoshida M
Abstract:
The DNA fragments of the 5' and 3' halves of the putative env gene predicted from the DNA sequence of human T-cell leukemia virus (HTLV) provirus were inserted into expression vectors pORF2 and pORF1, respectively, and two hybrid proteins composed of env polypeptides and beta-galactosidase were efficiently produced in Escherichia coli. The hybrid proteins containing the NH2-terminal (EH9) and COOH-terminal (EA1) halves were both immunologically reactive with sera from adult T-cell leukemia patients, demonstrating the utility of the hybrid proteins for diagnosis of HTLV infection. Rabbit antisera against these hybrid proteins detected the two glycoproteins gp62 and gp46, which were previously identified as HTLV env gene products. With these rabbit antisera, two properties of the env gene products were studied. (i) The antisera inhibited syncytia formation of cat S+L- cells induced by HTLV, suggesting that one or both of the env gene products of HTLV, gp62 and gp46, are involved in induction of cell fusion. (ii) The env product gp62 or gp46 or both products are exposed on the surface of HTLV-infected cells and might modulate the proliferation of HTLV-infected T cells in the host because the antisera against the hybrid proteins were cytotoxic on HTLV-producing cell lines. The latter conclusion also is supported by the fact that adult T-cell leukemia patients and healthy HTLV carriers have antibodies to the env gene products.
Keywords: Adult Animal Antigen-Antibody Complex Base Sequence Cell Line Cytotoxicity, Immunologic Escherichia coli/*GENETICS *Genes, Structural *Genes, Viral Human HTLV-BLV Viruses/*GENETICS Immune Sera Leukemia/*MICROBIOLOGY Leukemia, Lymphocytic Nucleic Acid Hybridization Plasmids Rats Support, Non-U.S. Gov't T-Lymphocytes/IMMUNOLOGY Viral Envelope Proteins/*GENETICS/ISOLATION & PURIF JOURNAL ARTICLE
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
